🇪🇸 Spain · EU Public Tender
Medicamentos exclusivos para la esclerosis múltiple: fampridina, interferón beta-1, natalizumab y fumarato dimetilo (2.ª prórroga PNSP 9/2018)
🏛️ Servicio Madrileño de Salud, Hospital Universitario La Paz · 📍 Madrid
2.1M €
Estimated value
—
Deadline
| Contract type | Supplies |
| CPV | 33600000 |
| Awarded to | Biogen Spain, S. L. U. |
Full tender details, bidder list, market context and related contracts available below.
Data sourced from TED — the Official Journal of the EU.